ALZECURE PHARMA AB
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and related neurodegenerative disorders. Conceptually, AlzeCure is an industry-standard incubator for novel projects. It comprises key professionals exhibiting complementary expertise from molecule to man.
ALZECURE PHARMA AB
Social Links:
Industry:
Pharmaceutical
Founded:
2012-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.alzecurepharma.se
Total Employee:
1+
Status:
Active
Contact:
+46 (0) 703-73 88 24.
Technology used in webpage:
SSL By Default Wordpress Plugins CrUX Dataset Cloudflare CDN Cloudflare CrUX Top 10m Browse Happy WordPress Multisite CryptX Modular Finance
Similar Organizations
Bioven Ltd.
Bioven Ltd. is a focused on the development of novel treatments for cancer
OctreoPharm Sciences
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.alzecurepharma.se Semrush global rank: 998.39 K Semrush visits lastest month: 27.61 K
- Host name: 104.18.25.240
- IP address: 104.18.25.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AlzeCure Pharma AB"
AlzeCure Pharma in brief
AlzeCure Pharma AB, Hälsovägen 7, SE-141 57 Huddinge, Sweden. Registration number: 559094-8302.See details»
History – AlzeCure Pharma
AlzeCure Pharma Overview | SignalHire Company Profile
Organization Website. alzecurepharma.com . Social Links. Phone Number +46 (0) 703-73 88 24. AlzeCure Pharma industries. Pharma Headquarters Location. Hälsovägen 7, Stockholm, …See details»
AlzeCure Pharma AB - Crunchbase Company Profile & Funding
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.See details»
AlzeCure Pharma - LinkedIn
FNCA Sweden AB is the company’s certified adviser: contact +46(0)8-528 00 399, [email protected]. For further information, please visit our website at www.alzecurepharma.se. WebsiteSee details»
AlzeCure Pharma AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AlzeCure Pharma AB of Huddinge, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
AlzeCure Pharma Company Profile - Office Locations, Competitors …
Oct 29, 2024 AlzeCure Pharma has 5 employees at their 1 location. See insights on AlzeCure Pharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
AlzeCure Pharma Financial Overview, Employee Count, and …
Alzecurepharma.se /alzecure. AlzeCure Pharma. Pharmaceuticals. Founded in 2016 +46-70-786-94-43. Stockholm, Stockholm County ...See details»
Management team – AlzeCure Pharma
Jan 7, 2020 Education/experience: Johan Sandin has a Ph.D. from Karolinska Institutet with a focus on neuropharmacology and with significant international academic and industrial experience (>20 years). He has worked at …See details»
AlzeCure Pharma - placera.se
Nov 20, 2024 [email protected] About AlzeCure Pharma AB (publ) AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug …See details»
AlzeCure Pharma - Overview, News & Similar companies - ZoomInfo
Www.alzecurepharma.se. Revenue $5.4 Million. Industry Manufacturing General Manufacturing . Recent News & Media. AlzeCure Publishes its Year-end Report for January - Septemb... Feb …See details»
AlzeCure Pharma - PitchBook
AlzeCure Pharma General Information Description. AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease.See details»
AlzeCure Pharma AB: AlzeCure Pharma publishes its Annual …
[email protected] The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on April 15, 2020. About AlzeCure …See details»
AlzeCure Pharma publishes its Annual Report for 2023
Apr 4, 2024 Organization. Management team; Board of directors; Founders; Scientific advisors; Collaborations and Partnership; History; Career. Open positions; ... please visit …See details»
AlzeCure Pharma Publishes its Annual Report for 2023
Apr 4, 2024 STOCKHOLM, SE / ACCESSWIRE / April 4, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical …See details»
Positive Results for AlzeCure - LINK Medical
May 29, 2023 FNCA Sweden AB, +46(0)8 528 00 399 [email protected], is the company’s Certified Adviser. For more information, please visit www.alzecurepharma.se. About Neuropathic pain. …See details»
AlzeCure publishes its interim report for January - placera.se
Nov 11, 2024 [email protected] About AlzeCure Pharma AB (publ) AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug …See details»
AlzeCure Pharma publishes its Annual Report for 2022
Apr 5, 2023 Organization. Management team; Board of directors; Founders; Scientific advisors; Collaborations and Partnership; History; Career. Open positions ... please visit …See details»
Alzheimer’s disease – AlzeCure Pharma
The figure below shows the expected growth in the number of cases of dementia between 2015 and 2050. The largest increase in number of cases of dementia and Alzheimer’s is expected to …See details»